Home › Philadelphia biotech firm gets $3.5M NIH contract to study Ebola, hepatits C viruses
 

Keywords :   


Philadelphia biotech firm gets $3.5M NIH contract to study Ebola, hepatits C viruses

2014-11-15 12:08:06| Biotech - Topix.net

The National Institutes of Health awarded Integral Molecular Inc. a five-year, $3.5 million contract to study the human immune response to the Ebola virus and hepatitis C virus. The funding will enable the Philadelphia biotechnology company to better understand how human antibodies protect, or fail to protect, people against such viruses.

Tags: study firm contract philadelphia

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
More »